Click it and Unblock the Notifications
Just In
Don't Miss
-
Apple Confirms Special Event for May 7: iPad Air, iPad Pro 2024 Models Expected -
TCS Vs Infosys Vs Wipro Shares, ADRs, Upcoming Dividends: Which Mega IT Stocks To Buy After Q4 Results? -
Who Won Yesterday's IPL Match 39? CSK vs LSG, IPL 2024 on April 23: Marcus Stoinis Fires 63-ball 124 To Quiet Chepauk -
Mirzapur 3 OTT Release Date, Platform: When Will Mirzapur Season 3 Premiere On Amazon Prime Video? -
Telangana Inter Manabadi 1st and 2nd Year Results 2024 to be Declared Tomorrow -
Chrysler Pacifica Marks Seven Years As Most Awarded Minivan With New Campaign -
Anant Ambani-Radhika Merchant's Wedding Function Details Are Out, Check out Ambani Bahu-To-Be's Chic Fashion! -
Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Consider setting up oxygen plant in Nagpur: Bombay High Court to Maharashtra
Nagpur, Apr 12: The Nagpur bench of Bombay High Court on Monday asked the Maharashtra government to consider setting up a unit or plant for production of oxygen at Nagpur for COVID-19 patients.
A division bench of Justices Z A Haq and A B Borkar was hearing a public interest litigation taken up suo motu (on its own) last year on the availability of medicines and Remdivisir injections in Nagpur amid the COVID-19 pandemic.
"We are taking up this matter urgently now looking at the situation prevailing today and we are trying to find out solutions with the help of different authorities," the court said.
Advocate SP Bhandarkar, appointed by the court for assistance, raised the issue of shortage of oxygen cylinders which was refuted by the Nagpur unit of the state's Food and Drugs Administration (FDA).
"Without going into the controversy (of whether or not there is a shortage), we suggest the Maharashtra government to consider establishing a unit/plant at Nagpur for production of oxygen," the court said.
The HC bench asked the state government, chief minister and Nagpur district guardian minister to look into matter urgently "looking at the situation prevailing today and that the situation is worsening day by day".
The bench was informed by advocate M G Bhangde, appearing for the FDA, that Remdivisir injections were being supplied to dedicated hospitals as per procedure and they were not being sold by pharmacists over the counter. Bhandarkar told the court there was lack of Remdivisir injections for needy patients due to illegal activities.
He said people are getting the injections under fake patient names and then selling the same in the black market.
The court asked the authorities to look into this issue. The bench also took note of a recent incident where a hospital was vandalised by the relatives of a patient who died there and asked the police to ensure safety of doctors and health workers. The court said it would hear the plea further on April 13.
